Davide Citterio

Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Rarity within rarity: complete response to chemoimmunotherapy in a patient with polymerase epsilon (POLE)-mutated locally advanced jejunal carcinoma.

Rarity within rarity: complete response to chemoimmunotherapy in a patient with polymerase epsilon (POLE)-mutated locally advanced jejunal carcinoma.

Journal: The oncologist

Published: April 23, 2026

Pancreaticojejunostomy Versus Neoprene-based Pancreatic Duct Occlusion in Pancreaticoduodenectomy for Patients at Intermediate-high Risk of Post-operative Pancreatic Fistula: A Comparative Cohort Study.

Pancreaticojejunostomy Versus Neoprene-based Pancreatic Duct Occlusion in Pancreaticoduodenectomy for Patients at Intermediate-high Risk of Post-operative Pancreatic Fistula: A Comparative Cohort Study.

Journal: Annals of surgery

Published: June 23, 2025

Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma.

Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma.

Journal: Surgical oncology

Published: November 13, 2024

Rescue pancreatic duct occlusion as pancreas-preserving procedure in case of emergency relaparotomy for grade C pancreatic fistulas after pancreaticoduodenectomy.

Rescue pancreatic duct occlusion as pancreas-preserving procedure in case of emergency relaparotomy for grade C pancreatic fistulas after pancreaticoduodenectomy.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: August 09, 2024

The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.

The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.

Journal: Current treatment options in oncology

Published: July 03, 2023

Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective.

Surgical Treatment of Hepatocellular Carcinoma: Multicenter Competing-risk Analysis of Tumor-related Death Following Liver Resection and Transplantation Under an Intention-to-treat Perspective.

Journal: Transplantation

Published: April 06, 2023

Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues.

Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues.

Journal: Cancers

Published: November 29, 2022

Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma.

Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma.

Journal: JAMA surgery

Published: November 23, 2022

Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria.

Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 03, 2022

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.

Journal: The British journal of surgery

Published: March 21, 2022

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.

Journal: World journal of gastroenterology

Published: January 27, 2022

Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers.

Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers.

Journal: Gut

Published: December 29, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026